Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved..
BACKGROUND: Surgical resection after neoadjuvant treatment is the main driver for improved survival in locally advanced pancreatic cancer (LAPC). However, the diagnostic performance of computed tomography (CT) imaging to evaluate the residual tumour burden at restaging after neoadjuvant therapy is low due to the difficulty in distinguishing neoplastic tissue from fibrous scar or inflammation. In this context, radiomics has gained popularity over conventional imaging as a complementary clinical tool capable of providing additional, unprecedented information regarding the intratumor heterogeneity and the residual neoplastic tissue, potentially serving in the therapeutic decision-making process.
AIM: To assess the capability of radiomic features to predict surgical resection in LAPC treated with neoadjuvant chemotherapy and radiotherapy.
METHODS: Patients with LAPC treated with intensive chemotherapy followed by ablative radiation therapy were retrospectively reviewed. One thousand six hundred and fifty-five radiomic features were extracted from planning CT inside the gross tumour volume. Both extracted features and clinical data contribute to create and validate the predictive model of resectability status. Patients were repeatedly divided into training and validation sets. The discriminating performance of each model, obtained applying a LASSO regression analysis, was assessed with the area under the receiver operating characteristic curve (AUC). The validated model was applied to the entire dataset to obtain the most significant features.
RESULTS: Seventy-one patients were included in the analysis. Median age was 65 years and 57.8% of patients were male. All patients underwent induction chemotherapy followed by ablative radiotherapy, and 19 (26.8%) ultimately received surgical resection. After the first step of variable selections, a predictive model of resectability was developed with a median AUC for training and validation sets of 0.862 (95%CI: 0.792-0.921) and 0.853 (95%CI: 0.706-0.960), respectively. The validated model was applied to the entire dataset and 4 features were selected to build the model with predictive performance as measured using AUC of 0.944 (95%CI: 0.892-0.996).
CONCLUSION: The present radiomic model could help predict resectability in LAPC after neoadjuvant chemotherapy and radiotherapy, potentially integrating clinical and morphological parameters in predicting surgical resection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
World journal of gastrointestinal oncology - 14(2022), 3 vom: 15. März, Seite 703-715 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rossi, Gabriella [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Computed tomography |
|---|
| Anmerkungen: |
Date Revised 25.03.2022 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4251/wjgo.v14.i3.703 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338516204 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338516204 | ||
| 003 | DE-627 | ||
| 005 | 20231226000839.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4251/wjgo.v14.i3.703 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1128.xml |
| 035 | |a (DE-627)NLM338516204 | ||
| 035 | |a (NLM)35321278 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rossi, Gabriella |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Surgical resection after neoadjuvant treatment is the main driver for improved survival in locally advanced pancreatic cancer (LAPC). However, the diagnostic performance of computed tomography (CT) imaging to evaluate the residual tumour burden at restaging after neoadjuvant therapy is low due to the difficulty in distinguishing neoplastic tissue from fibrous scar or inflammation. In this context, radiomics has gained popularity over conventional imaging as a complementary clinical tool capable of providing additional, unprecedented information regarding the intratumor heterogeneity and the residual neoplastic tissue, potentially serving in the therapeutic decision-making process | ||
| 520 | |a AIM: To assess the capability of radiomic features to predict surgical resection in LAPC treated with neoadjuvant chemotherapy and radiotherapy | ||
| 520 | |a METHODS: Patients with LAPC treated with intensive chemotherapy followed by ablative radiation therapy were retrospectively reviewed. One thousand six hundred and fifty-five radiomic features were extracted from planning CT inside the gross tumour volume. Both extracted features and clinical data contribute to create and validate the predictive model of resectability status. Patients were repeatedly divided into training and validation sets. The discriminating performance of each model, obtained applying a LASSO regression analysis, was assessed with the area under the receiver operating characteristic curve (AUC). The validated model was applied to the entire dataset to obtain the most significant features | ||
| 520 | |a RESULTS: Seventy-one patients were included in the analysis. Median age was 65 years and 57.8% of patients were male. All patients underwent induction chemotherapy followed by ablative radiotherapy, and 19 (26.8%) ultimately received surgical resection. After the first step of variable selections, a predictive model of resectability was developed with a median AUC for training and validation sets of 0.862 (95%CI: 0.792-0.921) and 0.853 (95%CI: 0.706-0.960), respectively. The validated model was applied to the entire dataset and 4 features were selected to build the model with predictive performance as measured using AUC of 0.944 (95%CI: 0.892-0.996) | ||
| 520 | |a CONCLUSION: The present radiomic model could help predict resectability in LAPC after neoadjuvant chemotherapy and radiotherapy, potentially integrating clinical and morphological parameters in predicting surgical resection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Computed tomography | |
| 650 | 4 | |a Locally advanced pancreatic cancer | |
| 650 | 4 | |a Predictive model | |
| 650 | 4 | |a Radiation oncology | |
| 650 | 4 | |a Radiomics | |
| 650 | 4 | |a Resectability | |
| 700 | 1 | |a Altabella, Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Simoni, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Benetti, Giulio |e verfasserin |4 aut | |
| 700 | 1 | |a Rossi, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Venezia, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Paiella, Salvatore |e verfasserin |4 aut | |
| 700 | 1 | |a Malleo, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Salvia, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Guariglia, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Bassi, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Cavedon, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Mazzarotto, Renzo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of gastrointestinal oncology |d 2009 |g 14(2022), 3 vom: 15. März, Seite 703-715 |w (DE-627)NLM204375533 |x 1948-5204 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:3 |g day:15 |g month:03 |g pages:703-715 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4251/wjgo.v14.i3.703 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2022 |e 3 |b 15 |c 03 |h 703-715 | ||